TYBLUME Drug Patent Profile
✉ Email this page to a colleague
When do Tyblume patents expire, and when can generic versions of Tyblume launch?
Tyblume is a drug marketed by Exeltis Usa Inc and is included in one NDA.
The generic ingredient in TYBLUME is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TYBLUME?
- What are the global sales for TYBLUME?
- What is Average Wholesale Price for TYBLUME?
Summary for TYBLUME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Drug Prices: | Drug price information for TYBLUME |
| What excipients (inactive ingredients) are in TYBLUME? | TYBLUME excipients list |
| DailyMed Link: | TYBLUME at DailyMed |
US Patents and Regulatory Information for TYBLUME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exeltis Usa Inc | TYBLUME | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 209405-001 | Mar 30, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
